• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用外照射放疗和立体定向体部放疗加量治疗无法手术切除的子宫内膜癌

Inoperable Endometrial Carcinoma Treated With External Beam Radiation and a Stereotactic Body Radiation Therapy Boost.

作者信息

Syed Rohail, Boggula Ramesh, Jaenisch Harriett S, Joiner Michael C, Miller Steven R

机构信息

Department of Oncology, Wayne State University School of Medicine, Detroit, USA.

出版信息

Cureus. 2025 Mar 28;17(3):e81363. doi: 10.7759/cureus.81363. eCollection 2025 Mar.

DOI:10.7759/cureus.81363
PMID:40291229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12034317/
Abstract

A significant comorbidity of endometrial cancer is severe obesity with a Body Mass Index (BMI) of greater than 40, which can dramatically limit treatment options such as surgery or brachytherapy. Alternative treatment options need to be investigated, and in this case report, we examine a female with severe obesity and a significantly enlarged uterus who was ineligible for surgery or intracavitary brachytherapy (ICBT). She subsequently underwent treatment with external beam radiation therapy (EBRT) alone to the pelvis, followed by a stereotactic radiation therapy boost (SBRT) to the uterus. Following treatment, her uterine bleeding subsided, and she is currently without evidence of disease.

摘要

子宫内膜癌的一个显著合并症是严重肥胖,体重指数(BMI)大于40,这会极大地限制手术或近距离放射治疗等治疗选择。需要研究替代治疗方案,在本病例报告中,我们检查了一名患有严重肥胖且子宫明显增大的女性,她不符合手术或腔内近距离放射治疗(ICBT)的条件。她随后仅接受了盆腔外照射放疗(EBRT),随后对子宫进行了立体定向放射治疗强化(SBRT)。治疗后,她的子宫出血消退,目前没有疾病迹象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/81bd09baf781/cureus-0017-00000081363-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/5aebacf6797c/cureus-0017-00000081363-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/fb00758c676b/cureus-0017-00000081363-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/e262e4d0ec1f/cureus-0017-00000081363-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/81bd09baf781/cureus-0017-00000081363-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/5aebacf6797c/cureus-0017-00000081363-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/fb00758c676b/cureus-0017-00000081363-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/e262e4d0ec1f/cureus-0017-00000081363-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42f7/12034317/81bd09baf781/cureus-0017-00000081363-i04.jpg

相似文献

1
Inoperable Endometrial Carcinoma Treated With External Beam Radiation and a Stereotactic Body Radiation Therapy Boost.采用外照射放疗和立体定向体部放疗加量治疗无法手术切除的子宫内膜癌
Cureus. 2025 Mar 28;17(3):e81363. doi: 10.7759/cureus.81363. eCollection 2025 Mar.
2
Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer.立体定向体部放射治疗作为不能手术的早期子宫内膜癌根治性治疗手段替代近距离放疗的剂量学可行性。
Radiat Oncol. 2014 Jul 24;9:164. doi: 10.1186/1748-717X-9-164.
3
Use of image-guided stereotactic body radiation therapy in lieu of intracavitary brachytherapy for the treatment of inoperable endometrial neoplasia.采用图像引导的立体定向体部放射治疗(SBRT)替代腔内近距离放疗(Brachytherapy)治疗无法手术的子宫内膜肿瘤。
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):129-35. doi: 10.1016/j.ijrobp.2012.02.058. Epub 2012 Apr 13.
4
Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.三联高剂量率近距离放疗用于早期医学上无法手术的子宫内膜癌:急性毒性的初步报告及与立体定向体部放疗的剂量学比较
Brachytherapy. 2017 Jan-Feb;16(1):141-146. doi: 10.1016/j.brachy.2016.10.004. Epub 2016 Nov 18.
5
Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.常规体外放射治疗加量在不适合腔内近距离放射治疗的日本宫颈癌患者中的临床结果。
Jpn J Clin Oncol. 2019 Mar 1;49(3):270-275. doi: 10.1093/jjco/hyy187.
6
CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy.CyberKnife 推量治疗用于无法接受近距离放疗的宫颈癌患者。
Front Oncol. 2012 Mar 21;2:25. doi: 10.3389/fonc.2012.00025. eCollection 2012.
7
Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).近距离放疗 boost(BT-boost)或立体定向体部放疗 boost(SBRT-boost)治疗高危前列腺癌(HR-PCa)。
Cancer Radiother. 2021 Jun;25(4):400-409. doi: 10.1016/j.canrad.2020.11.004. Epub 2021 Jan 18.
8
To analyze the impact of intracavitary brachytherapy as boost radiation after external beam radiotherapy in carcinoma of the external auditory canal and middle ear: a retrospective analysis.分析腔内近距离放射治疗作为外耳道和中耳癌外照射放疗后补充放疗的影响:一项回顾性分析。
J Cancer Res Ther. 2014 Apr-Jun;10(2):342-6. doi: 10.4103/0973-1482.136624.
9
Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy.Ⅰ/Ⅱ期立体定向体部放疗在不适合腔内近距离放疗的宫颈癌患者中的应用。
Jpn J Radiol. 2024 Aug;42(8):909-917. doi: 10.1007/s11604-024-01566-8. Epub 2024 Apr 16.
10
Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report.使用改良型Rotte-y施源器近距离治疗不可手术切除的子宫内膜癌:一例报告
Cureus. 2024 Oct 27;16(10):e72462. doi: 10.7759/cureus.72462. eCollection 2024 Oct.

本文引用的文献

1
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.错配修复缺陷作为子宫内膜癌的预测和预后生物标志物:免疫组织化学染色模式及临床意义的综述。
Int J Mol Sci. 2024 Jan 15;25(2):1056. doi: 10.3390/ijms25021056.
2
Stages I-III Inoperable Endometrial Carcinoma: A Retrospective Analysis by the Gynaecological Cancer GEC-ESTRO Working Group of Patients Treated with External Beam Irradiation and 3D-Image Guided Brachytherapy.I-III期不可手术切除的子宫内膜癌:妇科癌症GEC-ESTRO工作组对接受体外照射和三维图像引导近距离放射治疗的患者的回顾性分析。
Cancers (Basel). 2023 Sep 27;15(19):4750. doi: 10.3390/cancers15194750.
3
Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma.
针对医学上无法手术的子宫内膜癌的根治性放射治疗。
Adv Radiat Oncol. 2022 Oct 25;8(1):101003. doi: 10.1016/j.adro.2022.101003. eCollection 2023 Jan-Feb.
4
Update on MRI in Evaluation and Treatment of Endometrial Cancer.磁共振成像在子宫内膜癌评估和治疗中的应用进展。
Radiographics. 2022 Nov-Dec;42(7):2112-2130. doi: 10.1148/rg.220070. Epub 2022 Aug 26.
5
Management of inoperable endometrial cancer.不可手术切除的子宫内膜癌的管理
Obstet Gynecol Sci. 2022 Jul;65(4):303-316. doi: 10.5468/ogs.21219. Epub 2022 Mar 28.
6
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma.错配修复缺陷作为分子分类子宫内膜癌的预测和预后生物标志物
Cancers (Basel). 2021 Jun 22;13(13):3124. doi: 10.3390/cancers13133124.
7
Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility.子宫内膜癌中P53免疫组化的解读:提高可重复性
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1(Iss 1 Suppl 1):S123-S131. doi: 10.1097/PGP.0000000000000488.
8
ER and PR expression and survival after endometrial cancer.子宫内膜癌的 ER 和 PR 表达与生存。
Gynecol Oncol. 2018 Feb;148(2):258-266. doi: 10.1016/j.ygyno.2017.11.027. Epub 2017 Dec 6.
9
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.探讨肥胖在子宫内膜癌风险、预防及治疗中的作用。
J Clin Oncol. 2016 Dec 10;34(35):4225-4230. doi: 10.1200/JCO.2016.69.4638. Epub 2016 Nov 7.
10
Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer.近距离放射治疗用于治疗医学上无法手术的子宫内膜癌的共识声明。
Brachytherapy. 2015 Sep-Oct;14(5):587-99. doi: 10.1016/j.brachy.2015.06.002. Epub 2015 Jul 15.